Asia Pacific Ocular Drug Delivery Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Technology (Implantable Ocular Drug Delivery Systems, Particulate Drug Delivery Systems, Nano-Particle Drug Delivery System, and Others), Formulation Type (Liposomes and Nanoparticles, Solution, Emulsion, Suspension, and Ointment), Disease Type (Glaucoma, Diabetic Retinopathy, Dry Eye Syndrome, Macular Degeneration, Cataract, Diabetic Macular Edema, and Others), and End User (Hospitals, Ophthalmic Clinics, and Ambulatory Surgical Centers)
Market Introduction
Asia Pacific consists of five major countries namely China, Japan, India, Australia, and South Korea. The market is also evaluated for the rest of countries in Asia Pacific. Japan holds the largest share of the Asia Pacific ocular drug delivery market. In Japan, a substantial increase or the higher increase in incidences of normal-tension glaucoma (NTG), which is a form of glaucoma, is found. The prevalence of glaucoma is majorly observed in the elderly population; until 2017, nearly four million people were registered for glaucoma in Japan. The country has improved its glaucoma treatment regimen. The improvement has introduced new antiglaucoma ophthalmic solutions and minimally invasive glaucoma surgeries for patients across the country. Similarly, the country has a considerable number of patients with a dry eye disease (DED), various studies were conducted in the country for dry eye disease. The results of the studies showed that the prevalence of the DED among the Japanese I relatively higher. The annual health plan cost was estimated at nearly US$ 323 for every patient in the country. Additionally, the country has rising numbers of diabetes patients, which is another leading cause of diabetic retinopathy. Among Japan's total population, nearly 7.7% of people living with diabetes are approximately 7.2 million adults in the country. The country is facing a decreasing number of ophthalmologists in the country. However, the country is among the important country in terms of the developments for the healthcare infrastructure.
The 2019 novel coronavirus (2019-nCoV), officially named COVID-19 by the WHO, has spread to more than 170 countries, including China prompting the WHO to declare the disease as a global pandemic. COVID-19 has had a tremendous impact on eye care delivery across the Asia Pacific region. In Bangladesh, all routine elective eye surgeries were postponed. Only emergency eye treatment was conducted only at outpatient departments. Moreover, patients were allowed to go to hospital only in the case of emergency. Similarly in India, outreach eye health services stopped largely thus impacting the rural communities. All elective surgeries were postponed. Non-cataract conditions like diabetic retinopathy and glaucoma patients affected due to break in follow-ups. Additionally, COVID-19 is having a tremendous impact on eye care in the Maldives. Due to the lock down people are not able to travel from one place to the other. Air and sea transport is at standstill and people from the outlying islands are not able to visit the nearest centre for eye care. A few centers in the capital Male are offering online consultations to patients. However, this has its limitations and healthcare professionals cannot do refractions online and a detailed anterior segment and posterior segment examinations is also not possible. Thus, COVID 19 is having a significant impact on the quality and quantity of eye care in the Maldives.
Get more information on this report :
Market Overview and Dynamics
The ocular drug delivery market in Asia Pacific is expected to grow US$ 5,608.56 million by 2028 from US$ 3,234.93 million in 2021. The market is estimated to grow at a CAGR of 8.2% from 2021 to 2028. Cataract, glaucoma, age-related macular degeneration, diabetic retinopathy, and unaddressed refractive error are among the leading causes of blindness or low vision. Most of the population have or had some eye disorder in their lifetime. As per the World Health Organization (WHO) report "Blindness and vision impairment" published in February 2021, around 2.2 billion people worldwide have a near or distance vision impairment. It has also estimated that the leading cause of vision loss or low vision is cataract (94 million) and uncorrected refractive errors (88.4 million). Further, the other common causes of vision loss are glaucoma (7.7 million), corneal opacities (4.2 million), diabetic retinopathy (3.9 million), and trachoma (2 million). Thus, the Burgeoning prevalence of eye disorders is likely to enhance the growth of the market.
Key Market Segments
Asia Pacific ocular drug delivery market is segmented based on technology, formulation type, disease type, end user. Based on technology, implantable ocular drug delivery systems segment accounted for the highest share in 2021. Based on formulation type, solution segment accounted for the highest share in 2021. Based on disease type, cataract segment accounted for the highest share in 2021. Based on end user hospitals segment accounted for the highest share in 2021.
Major Sources and Companies Listed
A few major primary and secondary sources referred to for preparing this report on ocular drug delivery market in Asia Pacific are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are AbbVie Inc.; Bausch Health Companies Inc.; Novartis AG; Clearside Biomedical, Inc.; and Taiwan Liposome Company, Ltd. among others.
Reasons to buy report
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Asia Pacific ocular drug delivery market
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in Asia Pacific ocular drug delivery market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the ocular drug delivery market as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution
Asia Pacific Ocular Drug Delivery Market Segmentation
Asia Pacific Ocular Drug Delivery Market – By Technology
- Implantable Ocular Drug Delivery Systems
- Particulate Drug Delivery Systems
- Nano-Particle Drug Delivery System
- Others
Asia Pacific Ocular Drug Delivery Market – By Formulation Type
- Solution
- Ointment
- Suspension
- Emulsion
- Liposomes and Nanoparticles
Asia Pacific Ocular Drug Delivery Market – By Disease type
- Cataract
- Dry Eye Syndrome
- Macular Degeneration
- Glaucoma
- Diabetic Retinopathy
- Diabetic Macular Edema
- Others
Asia Pacific Ocular Drug Delivery Market – By End User
- Hospitals
- Ophthalmic Clinics
- Ambulatory Surgical Centers
Asia Pacific Ocular Drug Delivery Market – By Country
- Japan
- China
- India
- South Korea
- Australia
- Rest of APAC
Asia Pacific Ocular Drug Delivery Market – Companies Mentioned
- AbbVie Inc.
- Bausch Health Companies Inc.
- Novartis AG
- Clearside Biomedical, Inc.
- Taiwan Liposome Company, Ltd.
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Asia Pacific Ocular Drug Delivery Market – By Technology
1.3.2 Asia Pacific Ocular Drug Delivery Market – By Formulation Type
1.3.3 Asia Pacific Ocular Drug Delivery Market – By Disease Type
1.3.4 Asia Pacific Ocular Drug Delivery Market – By End User
1.3.5 Asia Pacific Ocular Drug Delivery Market – By Country
2. Asia Pacific Ocular Drug Delivery Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Asia Pacific Ocular Drug Delivery – Market Landscape
4.1 Overview
4.2 Expert Opinions
5. Asia Pacific Ocular Drug Delivery Market– Key Market Dynamics
5.1 Market Drivers
5.1.1 Burgeoning Prevalence of Eye Disorders
5.1.2 Accelerated Research on Ocular Drug Delivery
5.2 Market Restraints
5.2.1 Difficulties Associated with Ocular Drug Delivery
5.3 Market Opportunities
5.3.1 Boosting Awareness About Vision Care
5.4 Future Trends
5.4.1 Rise of Innovative Products
5.5 Impact analysis
6. Asia Pacific Ocular Drug Delivery – Market Analysis
6.1 Asia Pacific Ocular Drug Delivery Market Revenue Forecast and Analysis
7. Asia Pacific Ocular Drug Delivery Market Analysis – By Technology
7.1 Overview
7.2 Asia Pacific Ocular Drug Delivery Market Share by Technology 2021 & 2028 (%)
7.3 Implantable Ocular Drug Delivery Systems
7.3.1 Overview
7.3.2 Implantable Ocular Drug Delivery Systems Market Revenue and Forecast to 2028 (US$ Million)
7.4 Particulate Drug Delivery Systems
7.4.1 Overview
7.4.2 Particulate Drug Delivery Systems Market Revenue and Forecast to 2028 (US$ Million)
7.5 Nano-Particle Drug Delivery System
7.5.1 Overview
7.5.2 Nano-Particle Drug Delivery System Market Revenue and Forecast to 2028 (US$ Million)
7.6 Others
7.6.1 Overview
7.6.2 Others Market Revenue and Forecast to 2028 (US$ Million)
8. Asia Pacific Ocular Drug Delivery Market Analysis – By Formulation Type
8.1 Overview
8.1.1 Asia Pacific Ocular Drug Delivery Market, By Formulation Type 2021 & 2028 (%)
8.2 Liposomes and Nanoparticles Market
8.2.1 Overview
8.2.2 Liposomes and Nanoparticles Market Revenue and Forecasts to 2028 (US$ Million)
8.3 Solution
8.3.1 Overview
8.3.2 Solution Market Revenue and Forecasts to 2028 (US$ Million)
8.4 Emulsion
8.4.1 Overview
8.4.2 Emulsion Market Revenue and Forecasts to 2028 (US$ Million)
8.5 Suspension
8.5.1 Overview
8.5.2 Suspension Market Revenue and Forecasts to 2028 (US$ Million)
8.6 Ointment
8.6.1 Overview
8.6.2 Ointment Market Revenue and Forecasts to 2028 (US$ Million)
9. Asia Pacific Ocular Drug Delivery Market Analysis – By Disease Type
9.1 Overview
9.2 Asia Pacific Ocular Drug Delivery Market Share by Disease Type 2021 & 2028 (%)
9.3 Cataract
9.3.1 Overview
9.3.2 Cataract Market Revenue and Forecast to 2028 (US$ Million)
9.4 Dry Eye Syndrome
9.4.1 Overview
9.4.2 Dry Eye Syndrome Market Revenue and Forecast to 2028 (US$ Million)
9.5 Macular Degeneration
9.5.1 Overview
9.5.2 Macular Degeneration Market Revenue and Forecast to 2028 (US$ Million)
9.6 Glaucoma
9.6.1 Overview
9.6.2 Glaucoma Market Revenue and Forecast to 2028 (US$ Million)
9.7 Diabetic Retinopathy
9.7.1 Overview
9.7.2 Diabetic Retinopathy Market Revenue and Forecast to 2028 (US$ Million)
9.8 Diabetic Macular Edema
9.8.1 Overview
9.8.2 Diabetic Macular Edema Market Revenue and Forecast to 2028 (US$ Million)
9.9 Others
9.9.1 Overview
9.9.2 Others Market Revenue and Forecast to 2028 (US$ Million)
10. Asia Pacific Ocular Drug Delivery Market Analysis – By End User
10.1 Overview
10.2 Ocular Drug Delivery Market Share, by End User, 2021 and 2028 (%)
10.3 Hospitals
10.3.1 Overview
10.3.2 Hospitals: Ocular Drug Delivery Market– Revenue and Forecast to 2028 (US$ Million)
10.4 Ophthalmic Clinics
10.4.1 Overview
10.4.2 Ophthalmic Clinics: Ocular Drug Delivery Market– Revenue and Forecast to 2028 (US$ Million)
10.5 Ambulatory Surgical Centers
10.5.1 Overview
10.5.2 Ambulatory Surgical Centers: Ocular Drug Delivery Market– Revenue and Forecast to 2028 (US$ Million)
11. Asia Pacific Ocular Drug Delivery Market – Country Analysis
11.1 Overview
11.1.1 Asia Pacific: Ocular Drug Delivery Market, by Country, 2021 & 2028 (%)
11.1.1.1 China: Ocular Drug Delivery Market – Revenue and Forecast to 2028 (USD Million)
11.1.1.1.1 China: Ocular Drug Delivery Market – Revenue and Forecast to 2028 (USD Million)
11.1.1.1.2 China: Ocular Drug Delivery Market, By Technology, 2019–2028 (USD Million)
11.1.1.1.3 China: Ocular Drug Delivery Market, By Formulation Type, 2019–2028 (USD Million)
11.1.1.1.4 China: Ocular Drug Delivery Market, by Disease Type, 2019–2028 (USD Million)
11.1.1.1.5 China: Ocular Drug Delivery Market, by End User, 2019–2028 (USD Million)
11.1.1.2 Japan: Ocular Drug Delivery Market – Revenue and Forecast to 2028 (USD Million)
11.1.1.2.1 Japan: Ocular Drug Delivery Market – Revenue and Forecast to 2028 (USD Million)
11.1.1.2.2 Japan: Ocular Drug Delivery Market, By Technology, 2019–2028 (USD Million)
11.1.1.2.3 Japan: Ocular Drug Delivery Market, By Formulation Type, 2019–2028 (USD Million)
11.1.1.2.4 Japan: Ocular Drug Delivery Market, by Disease Type, 2019–2028 (USD Million)
11.1.1.2.5 Japan: Ocular Drug Delivery Market, by End User, 2019–2028 (USD Million)
11.1.1.3 India: Ocular Drug Delivery Market – Revenue and Forecast to 2028 (USD Million)
11.1.1.3.1 India: Ocular Drug Delivery Market – Revenue and Forecast to 2028 (USD Million)
11.1.1.3.2 India: Ocular Drug Delivery Market, By Technology, 2019–2028 (USD Million)
11.1.1.3.3 India: Ocular Drug Delivery Market, By Formulation Type, 2019–2028 (USD Million)
11.1.1.3.4 India: Ocular Drug Delivery Market, by Disease Type, 2019–2028 (USD Million)
11.1.1.3.5 India: Ocular Drug Delivery Market, by End User, 2019–2028 (USD Million)
11.1.1.4 Australia: Ocular Drug Delivery Market – Revenue and Forecast to 2028 (USD Million)
11.1.1.4.1 Australia: Ocular Drug Delivery Market – Revenue and Forecast to 2028 (USD Million)
11.1.1.4.2 Australia: Ocular Drug Delivery Market, By Technology, 2019–2028 (USD Million)
11.1.1.4.3 Australia: Ocular Drug Delivery Market, By Formulation Type, 2019–2028 (USD Million)
11.1.1.4.4 Australia: Ocular Drug Delivery Market, by Disease Type, 2019–2028 (USD Million)
11.1.1.4.5 Australia: Ocular Drug Delivery Market, by End User, 2019–2028 (USD Million)
11.1.1.5 South Korea: Ocular Drug Delivery Market – Revenue and Forecast to 2028 (USD Million)
11.1.1.5.1 South Korea: Ocular Drug Delivery Market – Revenue and Forecast to 2028 (USD Million)
11.1.1.5.2 South Korea: Ocular Drug Delivery Market, By Technology, 2019–2028 (USD Million)
11.1.1.5.3 South Korea: Ocular Drug Delivery Market, By Formulation Type, 2019–2028 (USD Million)
11.1.1.5.4 South Korea: Ocular Drug Delivery Market, by Disease Type, 2019–2028 (USD Million)
11.1.1.5.5 South Korea: Ocular Drug Delivery Market, by End User, 2019–2028 (USD Million)
11.1.1.6 Rest of Asia Pacific: Ocular Drug Delivery Market – Revenue and Forecast to 2028 (USD Million)
11.1.1.6.1 Rest of Asia Pacific: Ocular Drug Delivery Market – Revenue and Forecast to 2028 (USD Million)
11.1.1.6.2 Rest of Asia Pacific: Ocular Drug Delivery Market, By Technology, 2019–2028 (USD Million)
11.1.1.6.3 Rest of Asia Pacific: Ocular Drug Delivery Market, By Formulation Type, 2019–2028 (USD Million)
11.1.1.6.4 Rest of Asia Pacific: Ocular Drug Delivery Market, by Disease Type, 2019–2028 (USD Million)
11.1.1.6.5 Rest of Asia Pacific: Ocular Drug Delivery Market, by End User, 2019–2028 (USD Million)
12. Impact Of COVID-19 Pandemic on Asia Pacific Ocular Drug Delivery Market
12.1 Impact Assessment of COVID-19 Pandemic
13. Industry Landscape
13.1 Overview
13.2 Organic Developments
13.2.1 Overview
13.3 Inorganic Developments
13.3.1 Overview
14. Company Profiles
14.1 AbbVie Inc.
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 Bausch Health Companies Inc.
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 Taiwan Liposome Company, Ltd.
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 Novartis AG
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Clearside Biomedical, Inc.
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
15. Appendix
15.1 About The Insight Partners
15.2 Glossary of Terms
LIST OF TABLES
Table 1. China: Ocular Drug Delivery Market, By Technology – Revenue and Forecast to 2028 (USD Million)
Table 2. China: Ocular Drug Delivery Market, By Formulation Type – Revenue and Forecast to 2028 (USD Million)
Table 3. China: Ocular Drug Delivery Market, by Disease Type – Revenue and Forecast to 2028 (USD Million)
Table 4. China: Ocular Drug Delivery Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 5. Japan: Ocular Drug Delivery Market, By Technology– Revenue and Forecast to 2028 (USD Million)
Table 6. Japan: Ocular Drug Delivery Market, By Formulation Type– Revenue and Forecast to 2028 (USD Million)
Table 7. Japan: Ocular Drug Delivery Market, by Disease Type – Revenue and Forecast to 2028 (USD Million)
Table 8. Japan: Ocular Drug Delivery Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 9. India: Ocular Drug Delivery Market, By Technology– Revenue and Forecast to 2028 (USD Million)
Table 10. India: Ocular Drug Delivery Market, By Formulation Type – Revenue and Forecast to 2028 (USD Million)
Table 11. India: Ocular Drug Delivery Market, by Disease Type – Revenue and Forecast to 2028 (USD Million)
Table 12. India: Ocular Drug Delivery Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 13. Australia: Ocular Drug Delivery Market, By Technology – Revenue and Forecast to 2028 (USD Million)
Table 14. Australia: Ocular Drug Delivery Market, By Formulation Type– Revenue and Forecast to 2028 (USD Million)
Table 15. Australia: Ocular Drug Delivery Market, by Disease Type – Revenue and Forecast to 2028 (USD Million)
Table 16. Australia: Ocular Drug Delivery Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 17. South Korea: Ocular Drug Delivery Market, By Technology – Revenue and Forecast to 2028 (USD Million)
Table 18. South Korea: Ocular Drug Delivery Market, By Formulation Type – Revenue and Forecast to 2028 (USD Million)
Table 19. South Korea: Ocular Drug Delivery Market, by Disease Type – Revenue and Forecast to 2028 (USD Million)
Table 20. South Korea: Ocular Drug Delivery Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 21. Rest of Asia Pacific: Ocular Drug Delivery Market, By Technology – Revenue and Forecast to 2028 (USD Million)
Table 22. Rest of Asia Pacific: Ocular Drug Delivery Market, By Formulation Type – Revenue and Forecast to 2028 (USD Million)
Table 23. Rest of Asia Pacific: Ocular Drug Delivery Market, by Disease Type– Revenue and Forecast to 2028 (USD Million)
Table 24. Rest of Asia Pacific: Ocular Drug Delivery Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 25. Organic Developments Done By Companies
Table 26. Inorganic Developments Done by Companies
Table 27. Glossary of Terms, Ocular Drug Delivery Market
LIST OF FIGURES
Figure 1. Asia Pacific Ocular Drug Delivery Market Segmentation
Figure 2. Asia Pacific Ocular Drug Delivery Market Segmentation, By Country
Figure 3. Asia Pacific Ocular Drug Delivery Market Overview
Figure 4. Implantable Ocular Drug Delivery Systems Segment Held the Largest Share of the Technology Segment in Ocular Drug Delivery Market
Figure 5. Japan to Show Significant Growth During Forecast Period
Figure 6. Asia Pacific Ocular Drug Delivery Market, Industry Landscape
Figure 7. Asia Pacific PEST Analysis
Figure 8. Ocular Drug Delivery Market Impact Analysis of Driver and Restraints
Figure 9. Asia Pacific Ocular Drug Delivery Market – Revenue Forecast and Analysis – 2020- 2028
Figure 10. Asia Pacific Ocular Drug Delivery Market Share by Technology 2021 & 2028 (%)
Figure 11. Implantable Ocular Drug Delivery Systems Market Revenue and Forecasts to 2028 (US$ Million)
Figure 12. Particulate Drug Delivery Systems Market Revenue and Forecasts to 2028 (US$ Million)
Figure 13. Nano-Particle Drug Delivery System Market Revenue and Forecasts to 2028 (US$ Million)
Figure 14. Others Market Revenue and Forecasts to 2028 (US$ Million)
Figure 15. Asia Pacific Ocular Drug Delivery Market, By Formulation Type 2021 & 2028 (%)
Figure 16. Liposomes and Nanoparticles Market Revenue and Forecasts to 2028 (US$ Million)
Figure 17. Solution Market Revenue and Forecasts to 2028 (US$ Million)
Figure 18. Emulsion Market Revenue and Forecasts to 2028 (US$ Million)
Figure 19. Suspension Market Revenue and Forecasts to 2028 (US$ Million)
Figure 20. Ointment Market Revenue and Forecasts to 2028 (US$ Million)
Figure 21. Asia Pacific Ocular Drug Delivery Market Share by Disease Type 2021 & 2028 (%)
Figure 22. Cataract Market Revenue and Forecasts to 2028 (US$ Million)
Figure 23. Dry Eye Syndrome Market Revenue and Forecasts to 2028 (US$ Million)
Figure 24. Macular Degeneration Market Revenue and Forecasts to 2028 (US$ Million)
Figure 25. Glaucoma Market Revenue and Forecasts to 2028 (US$ Million)
Figure 26. Diabetic Retinopathy Market Revenue and Forecasts to 2028 (US$ Million)
Figure 27. Diabetic Macular Edema Market Revenue and Forecasts to 2028 (US$ Million)
Figure 28. Others Market Revenue and Forecasts to 2028 (US$ Million)
Figure 29. Ocular Drug Delivery Market Share, by End User, 2021 and 2028 (%)
Figure 30. Hospitals: Ocular Drug Delivery Market– Revenue and Forecast to 2028 (US$ Million)
Figure 31. Ophthalmic Clinics: Ocular Drug Delivery Market– Revenue and Forecast to 2028 (US$ Thousand)
Figure 32. Ambulatory Surgical Centers: Ocular Drug Delivery Market– Revenue and Forecast to 2028 (US$ Thousand)
Figure 33. Asia Pacific: Ocular Drug Delivery Market, by Key Country – Revenue (2021) (USD Million)
Figure 34. Asia Pacific: Ocular Drug Delivery Market, by Country, 2021 & 2028 (%)
Figure 35. China: Ocular Drug Delivery Market – Revenue and Forecast to 2028 (USD Million)
Figure 36. Japan: Ocular Drug Delivery Market – Revenue and Forecast to 2028 (USD Million)
Figure 37. India: Ocular Drug Delivery Market – Revenue and Forecast to 2028 (USD Million)
Figure 38. Australia: Ocular Drug Delivery Market – Revenue and Forecast to 2028 (USD Million)
Figure 39. South Korea: Ocular Drug Delivery Market – Revenue and Forecast to 2028 (USD Million)
Figure 40. Rest of Asia Pacific: Ocular Drug Delivery Market – Revenue and Forecast to 2028 (USD Million)
Figure 41. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
- AbbVie Inc.
- Bausch Health Companies Inc.
- Novartis AG
- Clearside Biomedical, Inc.
- Taiwan Liposome Company, Ltd.
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Asia Pacific ocular drug delivery market
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in Asia Pacific ocular drug delivery market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the ocular drug delivery market as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution